How our Clinical Academic Groups are tackling some of the biggest health issues in our community today.
Congratulations to Ms Ainslie Cahill AM
Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE) is delighted to announce that Ms Ainslie Cahill, SPHERE’s Leader in Consumer and Community Involvement and Engagement, has been appointed as a member of the Council for the National Health and Medical Research Council (NHMRC). We congratulate Ainslie on her appointment which is clear recognition of her contribution to, and expertise in, Consumer and Community Involvement in research.
Join Us
Maridulu Budyari Gumal, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) has partnered with Join Us to save lives and improve the health of all Australians and we need your help!
On the Road to Smarter Stroke Care
“Using improved medications, like Tenecteplase, with telehealth and stroke-ready ambulances will mean more Australians will receive urgent pre-hospital care within the precious treatment window where we can really make a difference.” - Professor Mark Parsons
‘A World Turned Topsy Turvy’: Maridulu Budyari Gumal - SPHERE CCI&KT Platform Uses Art to Communicate COVID-19 Experiences
The 'Topsy Turvy' exhibition – created through a unique collaboration with SPHERE Council members and the SPHERE CCI&KT Strategic Platform – uses art to document, share, and generate new insights into COVID-19 experiences.
Announcement of the Executive Director for Maridulu Budyari Gumal - SPHERE
I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE). He commenced in the role on 1 July 2021.
Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group
The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.